Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
15.75
+0.82 (5.49%)
Nov 3, 2026, 4:00 PM EST - Market closed
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $1.01 billion as of November 3, 2026. It is the 9,788th most valuable company in the world and the 2,221st biggest in the United States. Its market cap has increased by 98.13% in one year.
Market Cap
1.01B
Enterprise Value
681.12M
1-Year Change
98.13%
Global Rank
Country Rank
#2,221 United States
Category
ChartMarket Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has increased from $829.45M to $1.01B, an increase of 22.20%. That is a compound annual growth rate of 3.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 1.01B | 65.77% |
| Dec 31, 2025 | 611.44M | -13.79% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Janux Therapeutics | 1.09B |
| Seaport Therapeutics | 1.08B |
| Odyssey Therapeutics | 1.03B |
| MoonLake Immunotherapeutics | 995.75M |
| ORIC Pharmaceuticals | 994.03M |
| Immatics | 967.08M |
| Latigo Biotherapeutics | 965.98M |
| City Therapeutics | 949.86M |